Document is current
Any future updates will be listed below
-
Authors
Grosser, Bianca
Emmerson, Jake https://orcid.org/0000-0002-8198-8043
Reitsam, Nic G. https://orcid.org/0000-0002-0070-3158
Cunningham, David https://orcid.org/0000-0001-5158-1069
Nankivell, Matthew
Langley, Ruth E. https://orcid.org/0000-0002-9706-016X
Allum, William H.
Trepel, Martin
Märkl, Bruno
Grabsch, Heike I. https://orcid.org/0000-0001-9520-6228
- License Information
-
More Information
Article History
Received: 18 June 2023
Revised: 13 November 2023
Accepted: 21 November 2023
First Online: 20 December 2023
Competing interests
: DC has received grant funding from MedImmune, Clovis, Eli Lilly, 4SC, Bayer, Celgene, Leap and Roche not related to the current study. HIG Grabsch received honoraria from Astra Zeneca and Bristol Myers Squibb not related to the study. MT has received honoraria from Janssen, Roche and MedUpdate not related to the study.
: This study was approved by the UK NRES Committee London-South East (IRAS ID 144220). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
